Amphastar Pharmaceuticals (29A.F) Q3 2024 Earnings

7AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
0.71
0.79
0.88
0.97

Details

Expected EPS
0.7070632545
Actual EPS
0.8605417999999999
Surprise EPS
0.15
Surprise Percent
+21.71%

Description

Amphastar Pharmaceuticals (29A.F) has reported earnings of 0.8605417999999999 per share for Q3 2024.

0 Comments

Share your thoughts